What is Bydureon (Exenatide)?

Bydureon is a brand name of the drug exenatide. It is manufactured by AstraZeneca, a global biopharmaceutical company. It is a Type 2 diabetes medication that is taken once per week and uses an extended-release delivery system. The drug is used to maintain healthy blood sugar levels and is proven to lower A1C.

Bydureon and weight loss

Bydureon is not a weight loss drug. However, clinical studies have shown that weight loss is a common side effect. In clinical studies lasting 24 to 26 weeks, Bydureon helped patients lose an average of four to six pounds from a starting point of 193 to 213 pounds. In these studies, Bydureon was taken alone or with other Type 2 diabetes oral medicines. However, results varied by patient.

Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.